NCT00005858 LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00005836 Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy Status COMPLETED Phase PHASE2
NCT00005807 Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00005645 ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment Status WITHDRAWN Phase PHASE2
NCT00005612 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00005590 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE3
NCT00005095 Specimen and Data Study for Ovarian Cancer Early Detection and Prevention Status RECRUITING Phase N/A
NCT00005051 Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer Status COMPLETED Phase PHASE2
NCT00005049 Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer Status COMPLETED Phase PHASE2
NCT00005046 Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00005029 Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer Status TERMINATED Phase PHASE2
NCT00005026 Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00005025 Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer Status UNKNOWN Phase PHASE2
NCT00005023 Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer Status COMPLETED Phase PHASE1
NCT00004934 Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Status COMPLETED Phase PHASE3
NCT00004921 High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery Status COMPLETED Phase PHASE3
NCT00004909 Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer Status COMPLETED Phase N/A
NCT00004895 Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00004876 Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer Status COMPLETED Phase PHASE2
NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer Status COMPLETED Phase PHASE1